Aaron G Roseberry
Overview
Explore the profile of Aaron G Roseberry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
892
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dunigan A, Roseberry A
Addict Neurosci
. 2023 May;
2.
PMID: 37220637
The mesolimbic dopamine system is the primary neural circuit mediating motivation, reinforcement, and reward-related behavior. The activity of this system and multiple behaviors controlled by it are affected by changes...
2.
Dunigan A, Olson D, Roseberry A
Neuropharmacology
. 2021 Aug;
197:108746.
PMID: 34371079
Increasing evidence indicates that the melanocortin and mesolimbic dopamine (DA) systems interact to regulate feeding and body weight. Because melanocortin-3 receptors (MC3R) are highly expressed in the ventral tegmental area...
3.
Dunigan A, Swanson A, Olson D, Roseberry A
J Comp Neurol
. 2020 Aug;
529(6):1157-1183.
PMID: 32856297
The mesolimbic dopamine (DA) system is involved in the regulation of multiple behaviors, including feeding, and evidence demonstrates that the melanocortin system can act on the mesolimbic DA system to...
4.
West K, Lawson V, Swanson A, Dunigan A, Roseberry A
Obesity (Silver Spring)
. 2019 Sep;
27(11):1874-1882.
PMID: 31562706
Objective: Amphetamine was formerly used as a treatment to combat obesity, but amphetamine's use as an appetite suppressant was discontinued because of its significant abuse potential. Most of the rewarding...
5.
Mitchell N, Roseberry A
Front Neurosci
. 2019 Aug;
13:805.
PMID: 31427922
Obesity is a significant problem, and increased food intake is thought to underlie much of the increase in obesity levels. Recently, there has been much discussion and debate about the...
6.
West K, Lu C, Olson D, Roseberry A
J Physiol
. 2019 May;
597(12):3217-3232.
PMID: 31054267
Key Points: Alpha-melanocyte stimulating hormone (α-MSH) is an anorexigenic peptide. Injection of the α-MSH analog MTII into the ventral tegmental area (VTA) decreases food and sucrose intake and food reward....
7.
Hannapel R, Ramesh J, Ross A, LaLumiere R, Roseberry A, Parent M
eNeuro
. 2019 Jan;
6(1).
PMID: 30693314
Memory of a recently eaten meal can serve as a powerful mechanism for controlling future eating behavior because it provides a record of intake that likely outlasts most physiological signals...
8.
West K, Roseberry A
J Neurophysiol
. 2017 May;
118(1):625-633.
PMID: 28469002
The mesocorticolimbic dopamine system, the brain's reward system, regulates many different behaviors including food intake, food reward, and feeding-related behaviors, and there is increasing evidence that hypothalamic feeding-related neuropeptides alter...
9.
Shanmugarajah L, Dunigan A, Frantz K, Roseberry A
Psychopharmacology (Berl)
. 2017 Mar;
234(11):1683-1692.
PMID: 28243712
Rationale And Objectives: Alpha-melanocyte stimulating hormone (αMSH) and agouti-related protein (AgRP) are antagonistic neuropeptides that play an important role in the control of feeding and body weight through their central...
10.
Stuhrman K, Roseberry A
J Neurophysiol
. 2015 Jul;
114(3):1734-45.
PMID: 26180119
Dopamine is an essential neurotransmitter that plays an important role in a number of different physiological processes and disorders. There is substantial evidence that the neuropeptide neurotensin interacts with the...